Operationally, Vericel completed the construction of its new corporate headquarters and manufacturing facility, with plans to initiate commercial manufacturing in 2026. The company is also exploring opportunities to commercialize MACI outside the U.S. and is on track to submit an IND for MACI Ankle™ in the first half of 2025.